The CTD² Network and Cancer Systems Biology Consortium organized a virtual symposium series titled “Multidisciplinary Approaches to Understand Cancer Treatment Resistance”. Please join us on 11/16, 11/17, 12/2, 12/16, and 12/17. Click here to view the registration website.
Publications
The authors incorporated existing knowledge of gene interactions to generate more accurate statistical predictions of gene interaction networks.
An shRNA screen identified the only lung cancer cell line in the panel to be sensitive to knockdown of MAP2K1 and thus sensitive to MEK1 inhibition.
Expression of cytochrome P450 makes cell lines sensitive to oxalamides and benzothiazoles.
These results implicate PDE3A modulators as candidate cancer therapeutic agents and demonstrate the power of predictive chemogenomics in small-molecule discovery.
Researchers describe methodology for detailed studies of human Neural crest cells (NCC), and clarifies roles for retinoids and bone morphogenetic proteins in the differentiation of human pluripotent stem cells to trunk NCC and to sympathoadrenal lineages.
The authors use a gain-of-function screening platform to clone and functionally assess mutations that occur at low frequency in pancreatic cancer
Investigators develop an algorithm to statistically analyze off-target effects of RNAi and CRISPR screens.
Research shows that extrinsic factors have a larger influence on cancer risk than intrinsic factors